Register entry
- Registered sites
- 18
- Active NDC listings
- 10
- Labeller names
- 3
- Live patents
- 0
- Countries
- 4
- Base
- China
Authorisation
Registered operations
Analytical testing18Active ingredient (API) manufacture13Finished drug manufacture10
Sites
Registered establishments
18| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| WuXi Biologics (Hangzhou FTZ) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | Room 305, Building 2, No.388, 16th Street Baiyang Sub-district, Qiantang District, Hangzhou, Zhejiang 31008, China (CHN) | Analytical testing, Active ingredient (API) manufacture | 3042736734712788047 |
| WuXi Biologics (Hangzhou) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | Floor 1-4, Building 3, Heke Technology Center, No. 500 Qiaoxin Road, Xiasha Sub-district, Qiantang District, Hangzhou, Zhejiang 310018, China (CHN) | Analytical testing, Active ingredient (API) manufacture | 3040977029708422897 |
| WuXi Biologics (Zhejiang) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | No.525, Qiaoxin Road, Xiasha Sub-district, Qiantang District, Hangzhou, Zhejiang 310018, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3023443270544478607 |
| WuXi Biologics (Shanghai FX) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | Room 2481, Building No.1, 1150 Lan Feng Road, Fengxian District, Shanghai, 201403, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3030269812554423382 |
| WuXi Biologics (Shanghai) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | 31 Yiwei Road, Pilot Free Trade Zone, Shanghai, 200131, China (CHN) | Analytical testing, Active ingredient (API) manufacture | 3012317728544367368 |
| WuXi Biologics Biosafety Testing (Shanghai) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | Building 10, No.860, Xinyang Road, Lingang Special Area, China (Shanghai) Pilot Free Trade Zone, Shanghai, 201422, China (CHN) | Analytical testing | 3034423545621179802 |
| WuXi Biologics (Hebei) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | No. 619, Cangning Road, High-tech Zone, Shijiazhuang, Hebei 050000, China (CHN) | Analytical testing, Active ingredient (API) manufacture | 3032341421415480208 |
| Suzhou Vaccines Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | Building 2 of Bio-pharmaceutical Industrial Park Phase 3, No.1 Xinze Road, Suzhou Industrial Park, Suzhou, Jiangsu 215009, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3030379046444251259 |
| Suzhou Vaccines Co., Ltd. DP17 SiteRegistrant: WuXi Biologics Co., Ltd. | Building 16, Zone C, Phase V Biomedical Industrial Park, No. 21 Chaoqian Road, Suzhou Industrial Park, Suzhou, 215009, China (CHN) | Analytical testing, Finished drug manufacture | 3030585419456417289 |
| WuXi Biologics (Suzhou) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | Units 101, 201, and 301, Building C37, 218 Xinghu Street, China (Jiangsu) Pilot Free Trade Zone Suzhou Area, Suzhou, Jiangsu 215123, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3038731911544568998 |
| WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | 1336 Wuzhong Avenue, Xinzhiyuan Building B, Wuzhong District, Suzhou, Jiangsu 215104, China (CHN) | Analytical testing | 3015655844544312968 |
| WuXi Biologics Co., Ltd. | 108 Meiliang Road, Mashan, Binhu District, Wuxi, Jiangsu 214092, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3010606982421298354 |
| WuXi XDC Co., Ltd.Registrant: WuXi Biologics Co., Ltd. | No.11 Xinhuihuan Road, Xinwu District, Wuxi, Jiangsu 214028, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3020119387415991961 |
| WuXi Biologics Germany GmbHRegistrant: WuXi Biologics Co., Ltd. | Aprather Weg 18 a, Wuppertal, 42113, Germany (DEU) | Analytical testing | 3032710919344733546 |
| WuXi Biologics Ireland LimitedRegistrant: WuXi Biologics Co., Ltd. | Dundalk Science and Technology Park, Mullagharlin, Dundalk, Louth A91 X56F, Ireland (IRL) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3026506583985712254 |
| WuXi Biologics USA, LLCRegistrant: WuXi Biologics Co., Ltd. | 7 Clarke Dr, Cranbury, New Jersey (NJ) 08512, United States (USA) | Analytical testing, Active ingredient (API) manufacture | 3039674215119329208 |
| Wuxi Biologics USA, LLCRegistrant: WuXi Biologics Co., Ltd. | 1 Cedarbrook Dr, Cranbury, New Jersey (NJ) 08512, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3017966592116741944 |
| Wuxi Biologics USA, LLCRegistrant: WuXi Biologics Co., Ltd. | 8 Applegate Dr, NJ, Robbinsville, New Jersey (NJ) 08691-2342, United States (USA) | Analytical testing, Finished drug manufacture | 3030266883119516918 |
Catalogue
Drug listings by form and route
1010 active NDC listings: 9 drug for further processing, 1 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 9, BULK INGREDIENT 1.
| Dosage form | NDCs |
|---|---|
| injection | 3 |
| injection, solution | 3 |
| injection, powder, lyophilized, for solution | 2 |
| liquid | 1 |
| powder, for solution | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| wuxi biologics co., ltd. | 5 |
| wuxi biologics co., ltd. | 4 |
| wuxi biologics co., ltd | 1 |
Catalogue
Marketed products
10| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Berahyaluronidase alfa | liquid | 71851-009BULK INGREDIENT |
| - | Cipaglucosidase alfa | powder, for solution | 71851-010DRUG FOR FURTHER PROCESSING |
| - | Dostarlimab | injection, solution | 71851-002DRUG FOR FURTHER PROCESSING |
| - | Ibalizumab | injection, solution | 71851-001DRUG FOR FURTHER PROCESSING |
| - | aflibercept-jbvf | injection | 71851-006DRUG FOR FURTHER PROCESSING |
| - | cipaglucosidase alfa-atga | injection, powder, lyophilized, for solution | 71851-004DRUG FOR FURTHER PROCESSING |
| - | denosumab-bnht | injection | 71851-008DRUG FOR FURTHER PROCESSING |
| - | pemivibart | injection | 71851-005DRUG FOR FURTHER PROCESSING |
| - | vilobelimab | injection, solution | 71851-003DRUG FOR FURTHER PROCESSING |
| - | zanidatamab | injection, powder, lyophilized, for solution | 71851-007DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
12- STA Pharmaceutical US LLCShanghai, CHN; Wuxi, CHN · 3 sites
- BrightGene Bio-Medical Technology Co., Ltd.Suzhou, CHN · 3 sites
- Bimeda, Inc.Shijiazhuang, CHN · 2 sites
- Taikun Pharmaceutical Technology IncCranbury, NJ; Shanghai, CHN · 2 sites
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Shijiazhuang, CHN · 2 sites
- Frontage Laboratories (Suzhou) Co.,Ltd.Suzhou, CHN · 2 sites
- Hangzhou Zhongmei Huadong Pharmaceutical Co., LtdHANGZHOU, CHN · 2 sites
- Shanghai Henlius Biopharmaceutical Co., Ltd.Shanghai, CHN · 2 sites
- Zencore Biologics Co., Ltd.Shanghai, CHN · 2 sites
- SGS North America Inc.Shanghai, CHN
- Baxter Healthcare CorporationShanghai, CHN
- Bayer Healthcare Manufacturing SrlWuppertal, DEU
Compare
Comparable companies in China
- STA Pharmaceutical US LLC7 sites · 0 NDC
- Asymchem Inc6 sites · 0 NDC
- Qilu Pharmaceutical Co., Ltd.5 sites · 57 NDC
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.4 sites · 28 NDC
- BrightGene Bio-Medical Technology Co., Ltd.4 sites · 19 NDC
- Bimeda, Inc.4 sites · 0 NDC
- Zhejiang Huahai Pharmaceutical Technology Co Ltd3 sites · 76 NDC
- Zhejiang Xianju Pharmaceutical Co., Ltd.3 sites · 38 NDC
- Zhejiang Hisun Pharmaceutical Co., Ltd.3 sites · 27 NDC
- Viwit Pharmaceutical Co., Ltd.3 sites · 5 NDC
Enquiry
Common questions
- Is WuXi Biologics Co., Ltd. FDA approved?
- WuXi Biologics Co., Ltd. holds 18 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are WuXi Biologics Co., Ltd.'s drugs manufactured?
- At registered sites in China, Germany, Ireland, the United States. The FDA register lists Hangzhou; Shanghai; Shijiazhuang; Suzhou; Wuxi; Wuppertal, and 3 more. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
- What drugs does WuXi Biologics Co., Ltd. make?
- 10 products are listed under WuXi Biologics Co., Ltd. in the openFDA NDC Directory, most often as injection; injection, solution; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.